Graham Capital Management, L.P. Biocryst Pharmaceuticals Inc Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 136,103 shares of BCRX stock, worth $1.51 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
136,103
Previous 97,257
39.94%
Holding current value
$1.51 Million
Previous $731,000
39.53%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$241 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$222 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$99.2 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$96.7 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$86.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $2.07B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...